Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $6.38 USD
Change Today -0.01 / -0.16%
Volume 41.1K
As of 10:21 AM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

radnet inc (RDNT) Key Developments

RadNet, Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Revises Earnings Guidance for the Fiscal Year 2015

RadNet, Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company’s total net revenue was $181,267,000 compared with $168,876,000 a year ago. Loss from operations was $1,946,000 compared with income of $7,548,000 a year ago. Loss before income taxes was $7,567,000 compared with $16,853,000 a year ago. Net loss attributable to the company common stockholders was $4,554,000 or $0.11 per basic and diluted share compared with $12,424,000 or $0.31 per basic and diluted share a year ago. Net cash provided by operating activities was $17,469,000 compared with net cash used in operating activities of $4,860,000 a year ago. Purchase of property and equipment was $19,826,000 compared with $17,047,000 a year ago. Adjusted EBITDA was $20,194,000 compared with $27,651,000 a year ago. At March 31, 2015, the company had $600.5 million of net debt, which is total debt less cash balance, and were drawn $24.7 million on a revolving $101 million line of credit. The company updated earnings guidance for the fiscal year 2015. For the year, the company expects revenue in the range of $785 million to $805 million against $745 million to $765 million expected previously, adjusted EBITDA in the range of $125 million to $135 million against $123 million to $133 million expected previously, capital expenditures in the range of $40 million to $45 million against $40 million to $45 million expected previously, cash interest expense in the range of $36 million to $40 million against $34 million to $38 million expected previously and free cash flow generation in the range of $42 million to $52 million against $40 million to $50 million expected previously.

RadNet, Inc., Q1 2015 Earnings Call, May 11, 2015

RadNet, Inc., Q1 2015 Earnings Call, May 11, 2015

RadNet, Inc. Presents at 16th Annual B. Riley & Co. Investor Conference, May-13-2015 04:30 PM

RadNet, Inc. Presents at 16th Annual B. Riley & Co. Investor Conference, May-13-2015 04:30 PM. Venue: Loews Hollywood Hotel, Los Angeles, California, United States.

RadNet, Inc. Presents at 12th Annual Craig-Hallum Institutional Investor Conference, May-27-2015

RadNet, Inc. Presents at 12th Annual Craig-Hallum Institutional Investor Conference, May-27-2015 . Venue: The Depot Renaissance Minneapolis Hotel, 225 South Third Avenue, Minneapolis, MN 55401, United States.

Radnet, Inc. Announces Consolidated Unaudited Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Earnings Guidance for the Year 2015

RadNet, Inc. announced consolidated unaudited earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported total net revenue of $185,552,000 against $178,338, a year ago. Income from operations was $14,876,000 against $13,704,000 a year ago. Income before taxes was $7,173,000 against $4,092,000 a year ago. Net income attributable to company was $4,205,000 against $1,243,000 a year ago. Basic and diluted earnings per share were $0.10 against $0.03 a year ago. Adjusted EBITDA was $32,000,000 against $31,850,000 a year ago. Affecting net income in the fourth quarter of 2014 were certain non-cash expenses and non-recurring items including: $431,000 of non-cash employee stock compensation expense resulting from the vesting of certain options and restricted stock; $265,000 of severance paid in connection with headcount reductions related to cost savings initiatives; $468,000 gain on the disposal of certain capital equipment; and $1.3 million of amortization of deferred financing fees and discount on issuance of debt related to existing credit facilities. For the year, the company reported total net revenue of $717,569,000 against $702,986,000 a year ago. Income from operations was $53,305,000 against $43,603,000 a year ago. Income before taxes was $3,652,000 against $5,886,000 a year ago. Net income attributable to company was $1,376,000 against $2,120,000 a year ago. Basic and diluted earnings per share were $0.03 against $0.05 a year ago. Net cash provided by operating activities was $61,004,000 against $66,422,000 a year ago. Purchase of imaging facilities was $9,428,000 against $7,223,000 a year ago. Purchase of property and equipment was $41,740,000 against $48,623,000 a year ago. Adjusted EBITDA was $126,513,000 against $112,843,000 a year ago. Excluding the loss on early extinguishment of senior notes from refinancing transaction, income before income taxes increased to $19.6 million for full-year 2014 from $5.9 million in 2013. Affecting net income in 2014 were certain non-cash expenses and non-recurring items including: $2.5 million of non-cash employee stock compensation expense resulting from the vesting of certain options and restricted stock; $1.2 million of severance paid in connection with headcount reductions related to cost savings initiatives; $1.1 million loss on the disposal of certain capital equipment; and $5.7 million of amortization and write off of deferred financing fees and discount on issuance of debt related to existing credit facilities and refinancing transaction. The company announced that it is anticipating increased revenue, EBITDA and free cash flow for 2015. The company have significant growth drivers in plan, including benefiting from capitation contracts it signed in late 2014, revenue from recently announced breast disease management program in the nation of Qatar and continuing confidence about ability to drive same-center procedural volumes. Its refinancing transaction in March of last year will result in lower cash interest expense for 2015 and capital expenditures will be lower in 2015 than in 2014 (as 2014 included approximately $12 million of one-time spending related to the purchase of equipment it was previously renting). The combination of the lower cash interest expense and capital expenditures will increase free cash flow in 2015. The company expects revenue is to be in the range between from of $745 million to $765 million. Adjusted EBITDA is to be in the range between from of $123 million to $133 million. Capital expenditures are to be in the range between from of $40 million to $45 million. Cash interest expense is to be in the range between from of $34 million to $38 million. Free cash flow generation is to be in the range between from of $40 million to $50 million.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RDNT:US $6.38 USD -0.01

RDNT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alliance HealthCare Services Inc $18.69 USD -0.4511
Enzo Biochem Inc $2.44 USD -0.03
Genomic Health Inc $27.22 USD -0.12
NeoGenomics Inc $5.31 USD -0.09
Otter Tail Corp $27.07 USD -0.36
View Industry Companies
 

Industry Analysis

RDNT

Industry Average

Valuation RDNT Industry Range
Price/Earnings 30.1x
Price/Sales 0.4x
Price/Book 60.5x
Price/Cash Flow 4.2x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RADNET INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.